Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 343

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10

Open access
Ravi, Vidhya M., Neidert, Nicolas, Will, Paulina, Joseph, Kevin, Maier, Julian P., Kückelhaus, Jan, Vollmer, Lea, Goeldner, Jonathan M., Behringer, Simon P., Scherer, Florian, Boerries, Melanie, Follo, Marie, Weiss, Tobias, Delev, Daniel, Kernbach, Julius, Franco, Pamela, Schallner, Nils, Dierks, Christine, Carro, Maria Stella, Hofmann, Ulrich G., Fung, Christian, Sankowski, Roman, Prinz, Marco, Beck, Jürgen, Salié, Henrike, Bengsch, Bertram, Schnell, Oliver, Heiland, Dieter Henrik · 2022 · Nature Communications

Abstract

Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response. Here we show, by applying an in-silico multidimensional model integrating spatially resolved and single-cell gene expression data of 45,615 immune cells from 12 tumor samples, that a subset of Interleukin-10-releasing HMOX1 + myeloid cells, spatially localizing to mesenchymal-like tumor regions, drive T-cell exhaustion and thus contribute to the immunosuppressive tumor microenvironment. These findings are validated using a human ex-vivo neocortical glioblastoma model inoculated with patient derived peripheral T-cells to simulate the immune compartment. This model recapitulates the dysfunctional transformation of tumor infiltrating T-cells. Inhibition of the JAK/STAT pathway rescues T-cell functionality both in our model and in-vivo, providing further evidence of IL-10 release being an important driving force of tumor immune escape. Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-28523-1

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 343

Metadata

Authors
Ravi, V. M., Neidert, N., Will, P., Joseph, K., Maier, J. P., Kückelhaus, J., Vollmer, L., Goeldner, J. M., Behringer, S. P., Scherer, F., Boerries, M., Follo, M., Weiss, T., Delev, D., Kernbach, J., Franco, P., Schallner, N., Dierks, C., Carro, M. S., Hofmann, U. G., Fung, C., Sankowski, R., Prinz, M., Beck, J., Salié, H., Bengsch, B., Schnell, O., & Heiland, D. H.
Venue
Nature Communications
Published
2022-02-17
Volume
13
Issue
1
Pages
925-925
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4213222228
Cited by
343
References
73
FWCI
25.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. https://app.cochat.ai/papers/10.1038/s41467-022-28523-1
The paper
Ravi, V. M., Neidert, N., Will, P., Joseph, K., Maier, J. P., Kückelhaus, J., Vollmer, L., Goeldner, J. M., Behringer, S. P., Scherer, F., Boerries, M., Follo, M., Weiss, T., Delev, D., Kernbach, J., Franco, P., Schallner, N., Dierks, C., Carro, M. S., . . . Heiland, D. H. (2022). T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nature Communications. https://doi.org/10.1038/s41467-022-28523-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.